Vertex Pharmaceuticals Inc / Ma

Clearbridge Investments, LLC VRTX

Report date

3/31/2026

Quarter

2026 Q1

Filed

5/13/2026

Shares

2,700,975

Value ($000)

1,206,093

Weight

1.0%

2013 Q4 - 2026 Q1 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	5/13/2026	1,206,093	1.0%	2,700,975	3/31/2026
2025 Q4	2/11/2026	1,296,689	1.0%	2,860,176	12/31/2025
2025 Q3	11/13/2025	1,036,187	0.8%	2,645,764	9/30/2025
2025 Q2	8/12/2025	680,205	0.6%	1,527,864	6/30/2025
2025 Q1	5/13/2025	814,096	0.7%	1,679,171	3/31/2025
2024 Q4	2/12/2025	745,340	0.6%	1,850,858	12/31/2024
2024 Q3	11/12/2024	917,163	0.7%	1,972,055	9/30/2024
2024 Q2	8/27/2024	979,955	0.8%	2,090,704	6/30/2024
2024 Q1	5/13/2024	1,015,119	0.8%	2,428,455	3/31/2024
2023 Q4	2/9/2024	1,054,893	0.9%	2,592,575	12/31/2023
2023 Q3	11/13/2023	1,023,463	1.0%	2,943,184	9/30/2023
2023 Q2	8/11/2023	1,109,017	1.0%	3,151,422	6/30/2023
2023 Q1	5/12/2023	1,051,622	1.0%	3,337,741	3/31/2023
2022 Q4	2/10/2023	1,006,722	1.0%	3,486,120	12/31/2022
2022 Q3	11/14/2022	1,129,454	1.1%	3,900,856	9/30/2022
2022 Q2	8/11/2022	1,195,709	1.1%	4,243,264	6/30/2022
2022 Q1	5/13/2022	1,344,714	1.0%	5,152,752	3/31/2022
2021 Q4	2/11/2022	1,141,202	0.8%	5,196,730	12/31/2021
2021 Q3	11/12/2021	927,339	0.7%	5,112,404	9/30/2021
2021 Q2	8/13/2021	1,004,640	0.7%	4,982,594	6/30/2021
2021 Q1	5/13/2021	1,186,453	0.9%	5,521,210	3/31/2021
2020 Q4	2/10/2021	1,010,691	0.8%	4,276,426	12/31/2020
2020 Q3	11/12/2020	1,216,725	1.0%	4,471,280	9/30/2020
2020 Q2	8/14/2020	1,209,731	1.1%	4,167,032	6/30/2020
2020 Q1	5/22/2020	913,988	1.0%	3,841,094	3/31/2020
2019 Q4	2/14/2020	905,168	0.7%	4,124,713	12/31/2019
2014 Q1	5/15/2014	513,242	0.6%	7,257,377	3/31/2014
2013 Q4	2/14/2014	512,779	0.6%	6,901,470	12/31/2013